Trying to control MRSA causes more problems than it solves

Journal of Hospital Infection

Volumn 39, Issue 2, 1998, Pages 85-93

  Barrett, S P ^a   Mummery, R V ^b   Chattopadhya, B ^c  

^a ST MARY S HOSPITAL   (United Kingdom)

^b CHASE FARM HOSPITAL   (United Kingdom)

^c WHIPPS CROSS UNIVERSITY HOSPITAL   (United Kingdom)

Author keywords

Infection control policies; MRSA

Indexed keywords

ANTIBIOTIC RESISTANCE; DISEASE TRANSMISSION; HEALTH CARE POLICY; INFECTION CONTROL; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; REVIEW; STAPHYLOCOCCUS INFECTION;

EID: 0031813199     PISSN: 01956701     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0195-6701(98)90322-X     Document Type: Note

References (71)

1. Sheppard MJ. Control of methicillin-resistant Staphylococcus aureus. J Hosp Infect 1996; 32: 73-75.
2. Teare EL, Barrett SP. Is it time to stop searching for MRSA? Br Med J 1997; 314: 666-667.
3. Barker KF. Infection control in hospitals - sink or swim. Br Med J 1997; 315: 1315-1316.
4. Revised guidelines for the control of epidemic methicillin-resistant Staphylococcus aureus. Report of a combined working party of the Hospital Infection Society and British Society for Anti-microbial Chemotherapy. J Hosp Infect 1990; 16: 351-377.
5. Barrett SP, Gill ON, Mellor JA, Bryant JC. A descriptive study of uncontrolled methicillin-resistant Staphylococcus aureus in a twin site general hospital. Postgrad Med J 1988; 64: 606-609.
6. Riley TV, Rouse IL. Methicillin-resistant Staphylococcus aureus in Western Australia 1983-1992. J Hosp Infect 1995; 29: 177-188.
7. Barrett SP, Teare EL, Sage R. Methicillin-resistant Staphylococcus aureus in three adjacent Health Districts of south-east England 1986-91. J Hosp Infect 1993; 24: 313-325.
8. Cox RA, Conquest C, Mallaghan C, Marples RR. A major outbreak of methicillin-resistant Staphylococcus aureus caused by a new phage-type (EMRSA-16). J Hosp Infect 1995; 29: 87-106.
9. Faoagali JL, Thong ML, Grant D. Ten years' experience with methicillin-resistant Staphylococcus aureus in a large Australian hospital. J Hosp Infect 1992; 20: 113-119.
10. Barrett SP. MRSA pathogenicity and bacteraemia. J Hosp Infect 1997; 37: 171-172.
11. Selkon JB, Stokes ER, Ingham HR. The role of an isolation unit in the control of methicillin-resistant staphylococci. J Hosp Infect 1980; 1: 41-16.
12. Duckworth GJ, Lothian JLE, Williams JD. Methicillin-resistant Staphylococcus aureus: report of an outbreak in a London teaching hospital, J Hosp Infect 1988; 11: 1-15.
13. Back NA, Linnemann CC Jr, Staneck JL, Kotagal UR. Control of methicillin-resistant Staphylococcus aureus in a neonatal intensive-care unit: use of intensive microbiologic surveillance and mupirocin. Infect Control Hosp Epidemiol 1996; 17: 227-231.
14. Kauffman CA, Terpenning MS, He X, Zarins LT, Ramsey MA, Jorgensen KA, Sottile WS, Bradley SF. Attempts to eradicate methicillin-resistant Staphylococcus aureus from a longterm-care facility with the use of mupirocin ointment. Am J Med 1993; 94: 371-378.
15. Humphreys H. Comparison of infections caused by methicillin-sensitive and methicillin-resistant Staphylococcus aureus. In: Ed. Cafferky M. Methicillin-resistant Staphylococcus aureus - Clinical Management and Laboratory Aspects. Marcel Dekker Inc., New York, 1992: 77-87.
16. Fraise AP, Mitchell K, O'Brien SJ, Oldfield K, Wise R. Methicillin-resistant Staphylococcus aureus (MRSA) in nursing homes in a major UK city: An anonymized point prevalence survey. Epidemiol Infect 1997; 118: 1-5.
17. Moreno F, Crisp C, Jorgensen JH, Patterson JE. Methicillin-resistant Staphylococcus aureus as a community organism. Clin Infect Dis 1995; 21: 1308-1312.
18. Durmaz B, Durmaz R, Sahin K. Methicillin resistance among staphylococci isolated from nosocomial and community infections and their resistant patterns against various antimicrobial agents, J Hosp Infect 1997; 37: 325-329.
19. Bacon AE, Jorgensen KA, Wilson KH, Kauffman CA. Emergence of nosocomial methicillin-resistant Staphylococcus aureus and therapy of colonized personnel during a hospital-wide out-break. Infect Control 1987; 8: 145-150.
20. Hill RLR, Duckworth GJ, Casewell MW. Elimination of nasal carriage of methicillin-resistant Staphylococcus aureus with mupirocin during a hospital outbreak. J Antimicrob Chemother 1988; 22: 377-384.
21. Cederna JE, Terpenning MS, Ensberg M, Bradley SF, Kauffman CA. Staphylococcus aureus nasal colonization in a nursing home: eradication with mupirocin. Infect Control Hosp Epidemiol 1990; 11: 13-16.
22. Barrett SP. The value of nasal mupirocin in containing an outbreak of methicillin-resistant Staphylococcus aureus in an orthopaedic unit. J Hosp Infect 1990; 15: 137-142.
23. Kauffman C, Terpenning M, He X, Ramsey M, Zarins SL, Bradley S. Use of mupirocin to decrease MRSA colonization in a long term care facility (abstract 33). 31st Interscience Conference on Antimicrobial Agents and Chemotherapy. Chicago, 1991.
24. Reagan DR, Doebbeling BN, Pfaller MA, Sheetz CT, Houston AK, Hollis RJ, Wenzel RP. Elimination of coincident Staphylococcus aureus nasal and hand carriage with intranasal application of mupirocin calcium ointment. Ann Inter Med 1991; 114: 101-106.
25. Jepsen OB. The role of an isolation unit in the control of hospital infection with methicillin-resistant staphylococci. J Hosp Infect 1980; 1: 363-364.
26. Barrett SP. Australian MRSA. J Hosp Infect 1993; 25: 218.
27. Vickery AM and the Australian Group for Antimicrobial Resistance. Strains of methicillin-resistant Staphylococcus aureus isolated in Australian hospitals from 1986 to 1990. J Hosp Infect 1993; 24: 139-151.
28. Riley TV, Pearman JW, Rouse IL. Changing epidemiology of methicillin-resistant Staphylococcus aureus in Western Australia. Med J Aust 1995; 163: 412-414.
29. Cox RA, Conquest C. Strategies for the management of healthcare staff colonized with epidemic methicillin-resistant Staphylococcus aureus. J Hosp Infect 1997; 35: 117-127.
30. Anonymous. Epidemic methicillin-resistant Staphylococcus aureus. Comm Dis Rep 1997; 7: 191.
31. Voss A, Miltovic D, Wallrauch-Schwarz C, Rosdahl VT, Braveny I. Methicillin-resistant Staphylococcus aureus in Europe. Eur J Clin Microbiol Infect Dis 1994; 13: 50-55.
32. Williams REO, Shooter RA, Eds. Hospital Coccal Infections. Association of Clinical Pathologists, Swan Press, London, 1957.
33. Walsh TJ, Vlahov D, Hansen SL, Sonnenberg E, Khabbaz R, Gadacz T, Standiford HC. Prospective microbiologic surveillance in control of nosocomial methicillin-resistant Staphylococcus aureus. Infect Control 1987; 8: 7-14.
34. Rimland D, Robertson B. Gastrointestinal carriage of methicillin-resistant Staphylococcus aureus. J Clin Microbiol 1986; 24: 137-138.
35. Bendall RP, Gonzalez-Ruiz A, Batiste L, Kelsey MC. Outcome of methicillin-resistant Staphylococcus aureus carriage. Lancet 1994; 334: 819.
36. Barrett SP, Mellor JA. Living with EMRSA-1. J Hosp Infect 1990; 15: 103-104.
37. Crossley K, Landesman B, Zaske D. An out-break of infections caused by strains of Staphylococcus aureus resistant to methicillin and aminoglycosides. J Infect Dis 1979; 139: 280-287.
38. Peacock JE Jnr, Marsik FJ, Wenzel RP. Methicillin resistant Staphylococcus aureus: introduction and spread within a hospital. Ann Intern Med 1980; 93: 526-532.
39. Lessing MPA, Jordens JZ, Bowler ICJ. When should healthcare workers be screened for methicillin-resistant Staphylococcus aureus? J Hosp Infect 1997; 34: 205-210.
40. Boyce JM, White RL, Causey WA, Lockwood WR. Burn units as a source of methicillin resistant Staphylococcus aureus infections, J Am Med Assoc 1983; 249: 2803-2807.
41. Bartzokas CA, Paton JH, Gibson MR et al. Control and eradication of methicillin resistant Staphylococcus aureus on a surgical unit. N Engl J Med 1984; 311: 1422-1425.
42. McNeill MM, Solomon SL. The epidemiology of MRSA. The Antimicrobic Newsletter 1985; 2: 49-56.
43. Berman DS, Schaeffer S, Simberkoff MS, Rahal JJ. Tourniquets and nosocomial methicillin-resistant Staphylococcus aureus infections. N Engl J Med 1986; 315: 514-515.
44. Maki DG, McCormick RD, Zilz MA, Stolz SM, Alvarado CJ. A MRSA outbreak in an SICU during universal precaution: new epidemiology for nosocomial MRSA: downside for universal precautions (abstract 473). 30th Interscience Conference on Antimicrobial Agents and Chemotherapy. Atlanta, 1990.
45. Marples RR, Reith S. Methicillin-resistant Staphylococcus aureus in England and Wales. Comm Dis Rep Rev 1992; 2: 25-29.
46. Cooke EM, Casewell MW, Emmerson AM, Gaston M, de Saxe M, Mayon-White R, Galbraith NS. Methicillin-resistant Staphylococcus aureus in the UK and Ireland. J Hosp Infect 1986; 8: 143-148.
47. Mackintosh CA, Marples RR, Kerr GE, Bannister BA. Surveillance of methicillin-resistant Staphylococcus aureus in England and Wales, 1986-1990. J Hosp Infect 1991; 18: 279-301.
48. Dornbusch K, King A, Phillips I, Legakis NJ. Antibiotic resistance levels in European blood and urine isolates. A collaborative study. Abstract 259. 7th Proceedings of the European Congress of Clinical Microbiology and Infectious Diseases, European Society of Clinical Microbiology and Infectious Diseases. Vienna, 1995.
49. Mehtar S, Drabu YJ, Mayet F. Expenses incurred during a 5-week epidemic methicillin-resistant Staphylococcus aureus outbreak, J Hosp Infect 1989; 13: 199-203.
50. Rao N, Jacobs S, Joyce L. Cost effective eradication of an outbreak of methicillin resistant Staphylococcus aureus in a community teaching hospital. Infect Control Hosp Epidemiol 1988; 9: 255-260.
51. Mulligan ME, Murray-Leisure KA, Ribner BS, Standiford HC, John JF, Korvick JA, Kauffman KA, Yu VL. Methicillin-resistant Staphylococcus aureus: A consensus review of the microbiology, pathogenesis, and epidemiology with implications for prevention and management. Am J Med 1993; 94: 313-324.
52. Jefferson RD, Harrison J. Healthcare workers are at risk from policies for controlling MRSA. Br Med J 1997; 315: 57.
53. Blumberg HM, Rimland D, Carroll DJ, Terry P, Wachsmote IK. Rapid development of ciprofloxacin resistance in methicillin susceptible and resistant Staphylococcus aureus. J Infect Dis 1991; 163: 1278-1285.
54. Marples RR, Speller DCE, Cookson BD. Prevalence of mupirocin resistance in Staphylococcus aureus. J Hosp Infect 1995; 29: 153-161.
55. Anonymous. Reduced susceptibility of Staphylococcus aureus to vancomycin - Japan, 1996. Morbid Mortal Week Rep 1997; 46: 624-626.
56. Ayliffe GA, Brightwell KM, Collins BJ, Lowbury BJ, Goonatilake PC, Etheridge RA. Surveys of hospital infection in the Birmingham region. I. Effect of age, sex, length of stay and antibiotic use on nasal carriage of tetracycline-resistant Staphylococcus aureus and on post-operative wound infection. J Hyg (London) 1977; 79: 299-314.
57. Levine DP, Cushing RD, Jui J, Brown WJ. Community-acquired methicillin-resistant Staphylococcus aureus endocarditis in the Detroit medical center. Ann Intern Med 1982; 97: 330-338.
58. McDonald M. The epidemiology of methicillin-resistant Staphylococcus aureus: surgical relevance 20 years on. Aust NZJ Surg 1997; 67: 682-685.
59. Emmerson AM, Enstone JE, Griffin M, Kelsey MC, Smyth ET. The Second National Prevalence Survey of infection in hospitals-overview of the results. J Hosp Infect 1996; 32: 175-190.
60. Pujol M, Peña C, Pallares R, Ariza J, Ayats J, Dominguez MA, Gudiol F. Nosocomial Staphylococcus aureus bacteremia among nasal carriers of methicillin-resistant and methicillin-susceptible strains. Am J Med 1996; 100: 509-516.
61. Romero-Vivas J, Rubio M, Fernandez C, Picazo JJ. Mortality associated with nosocomial bacteremia due to methicillin resistant Staphylococcus aureus. Clin Infect Dis 1995; 21: 1417-1423.
62. French GL, Cheng AFB, Ling JML, Mo P, Donnan S. Hong Kong strains of methicillin-resistant and methicillin-sensitive Staphylococcus aureus have similar virulence. J Hosp Infect 1990; 15: 117-125.
63. Lewis E, Saravoltaz LD. Comparison of methicillin-resistant and methicillin-sensitive bacteremia. Am J Infect Control 1985; 13: 109-114.
64. Catchpole C, Wise R, Fraise A. MRSA bacteraemia. J Hosp Infect 1997; 35: 159-161.
65. Cutler RR. Relationship between antibiotic resistance, the production of 'virulence factors' and virulence for experimental animals in Staphylococcus aureus. J Med Microbiol 1979; 12: 55-62.
66. Moorman D, Mandell GL. Characteristics of rifampin-resistant variants obtained from clinical isolates of Staphylococcus aureus. Antimicrob Agents Chemother 1981; 20: 709-713.
67. Collopy BT, Dalton M, Wright C, Mullany C. Comparison of the clinical significance of methicillin-resistant and methicillin-sensitive Staphylococcus aureus. Med J Aust 1984; 140: 211-214.
68. Casewell MW. Epidemiology and control of the modern methicillin-resistant Staphylococcus aureus in the UK. J Hosp Infect 1985; 7 (Suppl. A): 1-11.
69. Kinsman O, Naidoo J, Noble WC. Some effects of plasmids coding for antibiotic resistance on the virulence of Staphylococcus aureus. Pathology 1985; 66: 325-332.
70. Lacey RW. Multi-resistant Staphylococcus aureus - a suitable case for inactivity? J Hosp Infect 1987; 9: 103-105.
71. Phillips I. Epidemic potential and pathogenicity in outbreaks of infection with EMRSA and EMREC. J Hosp Infect 1991; 18 (Suppl. A): 197-201.